Wednesday, September 9, 2026

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

Near $90 a Barrel? Oil Prices Surge as Middle East Uncertainty Grows

With escalating tensions in the Middle East,...

Could Bombing Iran Make North Korea Think Twice? Experts Weigh In

U.S. experts discuss how airstrikes on Iran may affect North Korea's nuclear ambitions and regional cooperation dynamics.

Tag: Reeve's Med

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Why the ArtiSential PRO is a Game Changer for Surgeons: 5 Key Features Explained

LIVSMED is expanding its surgical device portfolio, focusing on its flagship product, the multi-joint laparoscopic instrument ArtiSential PRO.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.